Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Managing Aggression: Effectiveness of Model-Based Standardized Patient Simulation

NCT07438340 · tracked via the Priya Life Science Turkey tracker
Sponsor
Yuksek Ihtisas University
Phase
Not applicable
Started
2026-02
Last updated
2026-02-27

Condition(s) studied

Aggression

Investigational drug(s) / intervention(s)

Standardized Patient Simulation Based on the De-Escalation Model in Simple Form

Standardized Patient Simulation Based on the De-Escalation Model in Simple Form: The intervention consists of a standardized patient-based simulation designed to improve nursing students' aggression management skills using the De-Escalation Model. During the simulation, a trained standardized patient portrays an acutely agitated psychiatric patient in a simulated clinical environment. Nursing students are expected to assess environmental safety, recognize early warning signs of aggression, apply the steps of the De-Escalation Model (setting limits, clarifying the situation, and problem-solving), and use therapeutic communication techniques to de-escalate patient agitation. The simulation session includes a briefing, an active simulation scenario, and a facilitated debriefing session led by the research team.

Study summary

This study aims to evaluate the effectiveness of standardized patient simulation based on "The De-Escalation Model in Simple Form" on nursing students' perceptions of aggression and perceived learning outcomes. Encountering aggressive and violent patient behavior is a common and challenging experience for nursing students. Simulation-based education offers experiential learning opportunities that can enhance students' confidence and clinical decision-making skills.

The study was designed using a convergent parallel mixed-methods approach. The quantitative component consists of a randomized controlled trial design in which participants will be randomly assigned to either the intervention group or the control group. Primary and secondary outcome measures related to aggression perception and perceived learning will be assessed post-test in both groups.

The intervention group will receive training based on the De-Escalation Model in Simple Form, followed by participation in an aggression management simulation with a standard patient. After the simulation, qualitative data will be collected from participants in the intervention group to examine their experiences, perceptions, and reactions to the intervention and simulation process.

Quantitative and qualitative findings will be analyzed to provide a comprehensive understanding of the intervention's effectiveness and implementation process. The results of this study are expected to contribute to evidence-based educational practices aimed at improving nursing students' skills in managing aggressive patient behavior.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * being 18 years of age * having taken and successfully passed the Mental Health and Psychiatric Nursing course * agreeing to participate in the study Exclusion Criteria: * refusing to participate in the study

Primary outcome measure(s)

  • Perception of Aggression (Perception of Aggression Scale) — Baseline, immediately after the intervention
    The scale consists of 29 items and has two subscales: Functional (acceptable-healthy reaction) and Dysfunctional (unacceptable-undesirable aggression). The scale is a five-point Likert-type scale. A score between 29 and 145 is obtained from the entire scale. A high mean score on the functional subscale indicates that aggression is perceived as functional/acceptable, while a high mean score on the dysfunctional subscale indicates that aggression is perceived as dysfunctional/unacceptable.

Trial sites (1)

FacilityCityRegionStatus
Yuksek Ihtisas University, Faculty of Health Sciences Ankara Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07438340 on ClinicalTrials.gov ↗ ← All trials in Turkey